Arecor Therapeutics plc (AIM:AREC)
62.50
0.00 (0.00%)
Jun 16, 2026, 8:00 AM GMT
Arecor Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3 | 3.24 | 5.09 | 4.77 | 18.32 |
Short-Term Investments | 3.13 | 0.02 | 1.66 | 8.04 | - |
Cash & Short-Term Investments | 6.13 | 3.26 | 6.75 | 12.81 | 18.32 |
Cash Growth | 88.21% | -51.76% | -47.27% | -30.08% | 532.02% |
Accounts Receivable | 0.14 | 2.53 | 2.27 | 0.66 | 0.71 |
Other Receivables | 0.52 | 1 | 1.06 | 2.16 | 0.86 |
Receivables | 0.66 | 3.53 | 3.32 | 2.82 | 1.57 |
Inventory | - | 0.48 | 0.77 | 1.13 | - |
Prepaid Expenses | 0.21 | 0.97 | 0.32 | 0.72 | 0.63 |
Other Current Assets | 0.7 | - | - | - | - |
Total Current Assets | 7.7 | 8.23 | 11.17 | 17.48 | 20.52 |
Property, Plant & Equipment | 0.3 | 0.4 | 0.83 | 0.84 | 0.33 |
Goodwill | - | - | 1.48 | 1.48 | - |
Other Intangible Assets | 0.02 | 0.03 | 1.81 | 1.92 | 0.03 |
Other Long-Term Assets | 0.09 | 0.06 | 0.08 | 0.05 | 0.05 |
Total Assets | 8.1 | 8.72 | 15.38 | 21.77 | 20.92 |
Accounts Payable | 0.3 | 1.02 | 2.25 | 1.71 | 0.52 |
Accrued Expenses | 0.94 | 1.78 | 2.13 | 1.27 | 1.17 |
Current Portion of Leases | 0.1 | 0.12 | 0.12 | 0.2 | 0.13 |
Current Income Taxes Payable | 0.08 | 0.09 | 0.1 | 0.12 | 0.09 |
Current Unearned Revenue | 0.07 | 0.09 | 0.23 | 0.21 | 0.35 |
Other Current Liabilities | 0.13 | 0.16 | 0.32 | 0.22 | 0.02 |
Total Current Liabilities | 1.61 | 3.26 | 5.15 | 3.73 | 2.27 |
Long-Term Leases | 0 | 0.11 | 0.22 | 0.09 | 0.11 |
Long-Term Deferred Tax Liabilities | - | - | 0.45 | 0.5 | - |
Other Long-Term Liabilities | 0.04 | 0.01 | 0.03 | - | - |
Total Liabilities | 1.65 | 3.37 | 5.85 | 4.31 | 2.37 |
Common Stock | 0.38 | 0.38 | 0.31 | 0.31 | 0.28 |
Additional Paid-In Capital | 34.68 | 34.68 | 28.98 | 28.98 | 23.35 |
Retained Earnings | -44.29 | -44.96 | -34.72 | -26.18 | -17.05 |
Comprehensive Income & Other | 15.69 | 15.25 | 14.97 | 14.35 | 11.97 |
Shareholders' Equity | 6.45 | 5.35 | 9.53 | 17.46 | 18.55 |
Total Liabilities & Equity | 8.1 | 8.72 | 15.38 | 21.77 | 20.92 |
Total Debt | 0.1 | 0.23 | 0.34 | 0.29 | 0.23 |
Net Cash (Debt) | 6.03 | 3.03 | 6.41 | 12.52 | 18.09 |
Net Cash Growth | 99.41% | -52.84% | -48.76% | -30.78% | 1902.77% |
Net Cash Per Share | 0.15 | 0.09 | 0.21 | 0.43 | 0.79 |
Filing Date Shares Outstanding | 37.76 | 37.76 | 30.63 | 30.62 | 27.84 |
Total Common Shares Outstanding | 37.76 | 37.76 | 30.63 | 30.62 | 27.84 |
Working Capital | 6.09 | 4.98 | 6.02 | 13.75 | 18.25 |
Book Value Per Share | 0.17 | 0.14 | 0.31 | 0.57 | 0.67 |
Tangible Book Value | 6.44 | 5.32 | 6.23 | 14.05 | 18.52 |
Tangible Book Value Per Share | 0.17 | 0.14 | 0.20 | 0.46 | 0.67 |
Machinery | 1.39 | 1.42 | 1.18 | 1.17 | 0.76 |
Leasehold Improvements | 0.14 | 0.16 | 0.14 | 0.1 | 0.08 |